Avalo Therapeutics, Inc.
Ticker: 1534120
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q3 FY2024 | Q3 FY2024 | Q3 FY2023 | Q2 FY2023 | Q2 FY2023 | Q1 FY2023 | Q1 FY2023 | Q1 FY2023 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 0.25+0.0% | 0.25+4.2% | 0.24-62.5% | 0.64+0.0% | 0.64+33.3% | 0.48+0.0% | 0.48+0.0% | 0.48 |
| Total Income | 0.25+0.0% | 0.25+4.2% | 0.24-62.5% | 0.64+0.0% | 0.64+33.3% | 0.48+0.0% | 0.48+0.0% | 0.48 |
| EXPENSES | ||||||||
| Expenditure | 13.11+0.0% | 13.11+228.6% | 3.99-48.8% | 7.79+0.0% | 7.79-16.0% | 9.27+0.0% | 9.27+0.0% | 9.27 |
| Tax | -0.01+0.0% | -0.01-200.0% | 0.01+0.0% | 0.01+0.0% | 0.01+0.0% | 0.01+0.0% | 0.01+0.0% | 0.01 |
| PROFIT | ||||||||
| PBT | 23.02+0.0% | 23.02+541.0% | -5.22+36.3% | -8.19+0.0% | -8.19+17.7% | -9.95+0.0% | -9.95+0.0% | -9.95 |
| Net Profit | 23.04+0.0% | 23.04+540.5% | -5.23+36.1% | -8.19+0.0% | -8.19+17.8% | -9.96+0.0% | -9.96+0.0% | -9.96 |
| KEY METRICS | ||||||||
| OPM % | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| NPM % | 100.00% | 100.00%+200.00pp | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
| EPS | 0.98+0.0% | 0.98+990.9% | -0.11+81.4% | -0.59+99.6% | -140.73+31.0% | -204.00+0.0% | -204.00-23900.0% | -0.85 |
Corporate Events
Board MeetingAVTX
202623Jun
Board Meeting
Appointment of Ron Philip to the Board of Directors, Compens…
SEC Filing ↗ Board MeetingAVTX
202611Jun
Board Meeting
Executive employment agreement amendments and Series C prefe…
SEC Filing ↗ Board MeetingAVTX
20262Jun
Board Meeting
Annual Meeting of Stockholders to elect directors, approve a…
SEC Filing ↗